An mRNA drug wiped out B cells in 3 patients with an autoimmune blood disorder — without cytokine release syndrome

Key Findings

🔬 Self-amplifying RNA programs stem cells for weeks from a single dose

• Researchers used self-amplifying RNA to deliver transcription factors and reporters into human induced pluripotent stem cells, sustaining protein expression for weeks without integrating into the genome — something conventional mRNA can't do.
• A single transfection drove the cells through differentiation into 3D cardiac spheroids, with functional reporters tracking heart cell activity and drug responses throughout the process.

🫁 mRNA therapy rescued lung cells in newborn mice after inflammatory injury

• Nanoparticles carrying stabilized FOXF1 mRNA — encoding a transcription factor critical for lung repair — were delivered intravenously to neonatal mice after a sepsis-mimicking injury. The particles selectively reached lung endothelial cells without hitting other organs.
• Treated mice showed reduced vascular leakage, improved endothelial barrier function, and better survival rates compared to untreated injured animals.

🎯 A sugar coating shifted nanoparticle delivery from liver to spleen

• Adding a mannose-conjugated lipid to standard lipid nanoparticles at 10 mol% flipped their destination: liver accumulation gave way to exclusive spleen localization in mice. Flow cytometry confirmed the particles were preferentially taken up by macrophages and dendritic cells via mannose receptor-mediated endocytosis.
• The formulation held up after freeze-thaw cycles with minimal toxicity, clearing a basic stability bar for practical use.

🧫 Click chemistry put a targeting protein on nanoparticles with single-site precision

• Using an expanded genetic code, researchers inserted one non-natural amino acid into a small targeting protein (a DARPin against mouse CD8), then used copper-free click chemistry to attach it to lipid nanoparticle surfaces at a defined, oriented position.
• In primary mouse T cell experiments, these targeted particles selectively transfected CD8-positive cytotoxic T cells while leaving other lymphocytes largely untouched.

🔩 How you dilute nanoparticles after mixing changes what they do in the body

• A design-of-experiments study compared two downstream manufacturing steps — off-line versus in-line dilution — across multiple lipid nanoparticle formulations. In-line dilution consistently produced smaller particles with lower encapsulation efficiency and more negative surface charge.
• Those physical differences had biological consequences: in-line particles drove stronger liver gene expression after intramuscular injection, while off-line particles produced stronger immune responses, suggesting dilution mode is a meaningful but underappreciated manufacturing variable.

🦠 An mRNA vaccine candidate cut urinary tract infection in a mouse recurrence model

• Researchers packaged mRNA encoding a modified version of FimH — a protein that helps uropathogenic E. coli stick to bladder walls — into lipid nanoparticles assembled on a ferritin scaffold. The vaccine was tested in a mouse model of recurrent urinary tract infection, which affects millions of people and is increasingly complicated by antibiotic resistance.
• The candidate produced immune responses consistent with reduced bladder colonization in the model.